España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Health Catalyst
HCAT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.42
-0.13
-2.34%
At close: -
$5.42
0.00
0.00%
After Hours: Feb 14, 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings in 10 days from now on Wed Feb 26th, after the market close
Health Catalyst (HCAT) Forecast
News
Earnings
Health Catalyst (HCAT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Health Catalyst (NASDAQ:HCAT) Stock
Health Catalyst Stock (NASDAQ: HCAT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 11, 2025
Beyond The Numbers: 8 Analysts Discuss Health Catalyst Stock
Benzinga Insights
Piper Sandler Maintains Overweight on Health ...
Benzinga Newsdesk
Tuesday, January 21, 2025
Wells Fargo Maintains Overweight on Health Ca...
Benzinga Newsdesk
Breaking Down Health Catalyst: 8 Analysts Share Their Views
Benzinga Insights
Canaccord Genuity Maintains Buy on Health Cat...
Benzinga Newsdesk
Wednesday, January 15, 2025
RBC Capital Maintains Sector Perform on Healt...
Benzinga Newsdesk
Monday, January 13, 2025
Health Catalyst Announces Acquisition Of Upfr...
Benzinga Newsdesk
Friday, January 10, 2025
Citigroup Maintains Buy on Health Catalyst, L...
Benzinga Newsdesk
Wednesday, January 08, 2025
Keybanc Upgrades Health Catalyst to Overweigh...
Benzinga Newsdesk
Tuesday, November 26, 2024
Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Piper Sandler Reiterates Overweight on Health...
Benzinga Newsdesk
Thursday, November 14, 2024
Stephens & Co. Maintains Equal-Weight on Heal...
Benzinga Newsdesk
Wednesday, November 13, 2024
Health Catalyst shares are trading higher aft...
Benzinga Newsdesk
The Latest Analyst Ratings For Health Catalyst
Benzinga Insights
Citigroup Maintains Buy on Health Catalyst, R...
Benzinga Newsdesk
Thursday, November 07, 2024
RBC Capital Maintains Sector Perform on Healt...
Benzinga Newsdesk
Wednesday, November 06, 2024
Health Catalyst Signs Definitive Agreement To...
Benzinga Newsdesk
CyncHealth Announces New Partnership With Hea...
Benzinga Newsdesk
Health Catalyst Narrows FY2024 Sales Guidance...
Benzinga Newsdesk
Health Catalyst Sees Q4 Sales $78.000M-84.000...
Benzinga Newsdesk
Health Catalyst Q3 2024 Adj. EPS $0.07 Misses...
Benzinga Newsdesk
Tuesday, October 08, 2024
What Analysts Are Saying About Health Catalyst Stock
Benzinga Insights
Evercore ISI Group Maintains Outperform on He...
Benzinga Newsdesk
Friday, October 04, 2024
Cantor Fitzgerald Reiterates Overweight on He...
Benzinga Newsdesk
Friday, September 20, 2024
Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on He...
Benzinga Newsdesk
Wednesday, September 04, 2024
JP Morgan Maintains Overweight on Health Cata...
Benzinga Newsdesk
Monday, August 26, 2024
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
Benzinga Insights
Piper Sandler Maintains Overweight on Health ...
Benzinga Newsdesk
Tuesday, August 20, 2024
Cantor Fitzgerald Reiterates Overweight on He...
Benzinga Newsdesk
Friday, August 09, 2024
Health Catalyst shares are trading lower afte...
Benzinga Newsdesk
The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on He...
Benzinga Newsdesk
Thursday, August 08, 2024
Stephens & Co. Maintains Equal-Weight on Heal...
Benzinga Newsdesk
Health Catalyst shares are trading higher aft...
Benzinga Newsdesk
Health Catalyst Announces Partnership Expansi...
Benzinga Newsdesk
Wednesday, August 07, 2024
Health Catalyst Sees Q3 2024 Revenue $74.5M-$...
Benzinga Newsdesk
Health Catalyst shares are trading lower afte...
Benzinga Newsdesk
Health Catalyst Q2 2024 Adj. EPS $0.12 Beats ...
Benzinga Newsdesk
Tuesday, July 09, 2024
A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
Benzinga Insights
Evercore ISI Group Maintains Outperform on He...
Benzinga Newsdesk
Monday, June 10, 2024
Time to Play 5 Top-Ranked Stocks With Rising P/E?
Zacks
Thursday, June 06, 2024
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
Piper Sandler Maintains Overweight on Health ...
Benzinga Newsdesk
Health Catalyst Acquires Carevive, A Leading ...
Benzinga Newsdesk
Tuesday, May 21, 2024
Peeling Back The Layers: Exploring Health Catalyst Through Analyst Insights
Benzinga Insights
Canaccord Genuity Maintains Buy on Health Cat...
Benzinga Newsdesk
Friday, May 10, 2024
Wells Fargo Maintains Overweight on Health Ca...
Benzinga Newsdesk
Thursday, May 09, 2024
Health Catalyst Sees FY24 Revenue $304.0M-$31...
Benzinga Newsdesk
Health Catalyst Sees Q2 2024 Revenue $73.5M-$...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
